ICI 169,369 selectively blocks 5-hydroxytryptamine2 receptors and lowers portal pressure in portal hypertensive rats. (Q41928566)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3181683 AND SRC:MED&resulttype=core&format=json

19 September 2019

title

ICI 169,369 selectively blocks 5-hydroxytryptamine2 receptors and lowers portal pressure in portal hypertensive rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3181683 AND SRC:MED&resulttype=core&format=json

19 September 2019

author name string

A J Kaumann

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3181683 AND SRC:MED&resulttype=core&format=json

19 September 2019

J S Morgan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3181683 AND SRC:MED&resulttype=core&format=json

19 September 2019

R J Groszmann

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3181683 AND SRC:MED&resulttype=core&format=json

19 September 2019

language of work or name

English

0 references

publication date

1 December 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3181683 AND SRC:MED&resulttype=core&format=json

19 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3181683 AND SRC:MED&resulttype=core&format=json

19 September 2019

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3181683 AND SRC:MED&resulttype=core&format=json

19 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3181683 AND SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

1601-1606

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3181683 AND SRC:MED&resulttype=core&format=json

Hypersensitivity of mesenteric veins to 5-hydroxytryptamine- and ketanserin-induced reduction of portal pressure in portal hypertensive rats

19 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(88)80084-2

Beneficial hemodynamic effects of ketanserin in patients with cirrhosis: possible role of serotonergic mechanisms in portal hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(88)80084-2

Mechanism of the Hypotensive Effect of Ketanserin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(88)80084-2

Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(88)80084-2

Comparison of the hemodynamic responses to ketanserin and prazosin in portal hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(88)80084-2

In vitro studies with ICI 169,369, a chemically novel 5-HT antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(88)80084-2

Convenient apparatus for recording contractions of isolated heart muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(88)80084-2

5HT2 receptors in the rat portal vein: desensitization following cumulative serotonin addition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(88)80084-2

Interaction of ketanserin and its metabolite ketanserinol with 5HT2 receptors in pulmonary and coronary arteries of calf

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(88)80084-2

A paradox: the 5-HT2-receptor antagonist ketanserin restores the 5-HT-induced contraction depressed by methysergide in large coronary arteries of calf. Allosteric regulation of 5-HT2-receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(88)80084-2

Hyposensitivity to vasopressin in a hemorrhaged-transfused rat model of portal hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(88)80084-2

Increased portal venous resistance hinders portal pressure reduction during the administration of beta-adrenergic blocking agents in a portal hypertensive model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(88)80084-2

10.1016/S0016-5085(88)80084-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3181683 AND SRC:MED&resulttype=core&format=json

19 September 2019

1 reference